ZOETIS INC (ZTS) Fundamental Analysis & Valuation
NYSE:ZTS • US98978V1035
Current stock price
116.33 USD
+2.98 (+2.63%)
At close:
116.36 USD
+0.03 (+0.03%)
After Hours:
This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZTS Profitability Analysis
1.1 Basic Checks
- In the past year ZTS was profitable.
- ZTS had a positive operating cash flow in the past year.
- In the past 5 years ZTS has always been profitable.
- In the past 5 years ZTS always reported a positive cash flow from operatings.
1.2 Ratios
- ZTS's Return On Assets of 17.28% is amongst the best of the industry. ZTS outperforms 95.83% of its industry peers.
- ZTS has a better Return On Equity (80.25%) than 99.48% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 21.95%, ZTS belongs to the top of the industry, outperforming 97.40% of the companies in the same industry.
- ZTS had an Average Return On Invested Capital over the past 3 years of 22.23%. This is significantly above the industry average of 13.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROIC | 21.95% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
1.3 Margins
- The Profit Margin of ZTS (28.23%) is better than 93.75% of its industry peers.
- In the last couple of years the Profit Margin of ZTS has grown nicely.
- ZTS has a better Operating Margin (38.54%) than 97.40% of its industry peers.
- In the last couple of years the Operating Margin of ZTS has grown nicely.
- With a decent Gross Margin value of 71.89%, ZTS is doing good in the industry, outperforming 79.17% of the companies in the same industry.
- ZTS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% |
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
2. ZTS Health Analysis
2.1 Basic Checks
- ZTS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- ZTS has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for ZTS has been reduced compared to 5 years ago.
- Compared to 1 year ago, ZTS has a worse debt to assets ratio.
2.2 Solvency
- ZTS has an Altman-Z score of 5.35. This indicates that ZTS is financially healthy and has little risk of bankruptcy at the moment.
- ZTS's Altman-Z score of 5.35 is fine compared to the rest of the industry. ZTS outperforms 78.65% of its industry peers.
- The Debt to FCF ratio of ZTS is 3.96, which is a good value as it means it would take ZTS, 3.96 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 3.96, ZTS belongs to the best of the industry, outperforming 85.94% of the companies in the same industry.
- A Debt/Equity ratio of 2.71 is on the high side and indicates that ZTS has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 2.71, ZTS is doing worse than 80.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Altman-Z | 5.35 |
ROIC/WACC2.43
WACC9.05%
2.3 Liquidity
- A Current Ratio of 3.03 indicates that ZTS has no problem at all paying its short term obligations.
- ZTS's Current ratio of 3.03 is in line compared to the rest of the industry. ZTS outperforms 52.60% of its industry peers.
- A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.94, ZTS is in line with its industry, outperforming 46.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 |
3. ZTS Growth Analysis
3.1 Past
- ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
- The Earnings Per Share has been growing by 10.77% on average over the past years. This is quite good.
- Looking at the last year, ZTS shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
- ZTS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.24% yearly.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
3.2 Future
- Based on estimates for the next years, ZTS will show a small growth in Earnings Per Share. The EPS will grow by 7.80% on average per year.
- The Revenue is expected to grow by 5.30% on average over the next years.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.9%
Revenue Next 2Y4.87%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ZTS Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 18.12 indicates a rather expensive valuation of ZTS.
- Based on the Price/Earnings ratio, ZTS is valued cheaply inside the industry as 84.38% of the companies are valued more expensively.
- ZTS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.75.
- The Price/Forward Earnings ratio is 16.44, which indicates a correct valuation of ZTS.
- 82.29% of the companies in the same industry are more expensive than ZTS, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 22.10. ZTS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.12 | ||
| Fwd PE | 16.44 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ZTS is valued cheaper than 83.33% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 83.85% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.51 | ||
| EV/EBITDA | 13.2 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ZTS may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)1.68
EPS Next 2Y8.92%
EPS Next 3Y8.7%
5. ZTS Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.64%, ZTS has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.70, ZTS pays a better dividend. On top of this ZTS pays more dividend than 91.15% of the companies listed in the same industry.
- ZTS's Dividend Yield is comparable with the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- The dividend of ZTS is nicely growing with an annual growth rate of 20.56%!
- ZTS has paid a dividend for at least 10 years, which is a reliable track record.
- ZTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)20.56%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- ZTS pays out 33.26% of its income as dividend. This is a sustainable payout ratio.
- The dividend of ZTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
ZTS Fundamentals: All Metrics, Ratios and Statistics
116.33
+2.98 (+2.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12 2026-02-12/bmo
Earnings (Next)05-04 2026-05-04/bmo
Inst Owners100.79%
Inst Owner Change4.39%
Ins Owners0.07%
Ins Owner Change3.87%
Market Cap49.11B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts77.6
Price Target150.27 (29.18%)
Short Float %4.12%
Short Ratio3.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-20 2026-04-20 (0.53)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-3.34%
PT rev (3m)-7.85%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)2.91%
EPS NY rev (1m)3.06%
EPS NY rev (3m)3.57%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.12 | ||
| Fwd PE | 16.44 | ||
| P/S | 5.19 | ||
| P/FCF | 21.51 | ||
| P/OCF | 16.91 | ||
| P/B | 14.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.2 |
EPS(TTM)6.42
EY5.52%
EPS(NY)7.08
Fwd EY6.08%
FCF(TTM)5.41
FCFY4.65%
OCF(TTM)6.88
OCFY5.91%
SpS22.43
BVpS7.89
TBVpS-1.03
PEG (NY)1.77
PEG (5Y)1.68
Graham Number33.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROCE | 27.58% | ||
| ROIC | 21.95% | ||
| ROICexc | 26.6% | ||
| ROICexgc | 40.59% | ||
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% | ||
| FCFM | 24.12% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Debt/EBITDA | 2.19 | ||
| Cap/Depr | 127.52% | ||
| Cap/Sales | 6.56% | ||
| Interest Coverage | 13.98 | ||
| Cash Conversion | 70.21% | ||
| Profit Quality | 85.41% | ||
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 5.35 |
F-Score6
WACC9.05%
ROIC/WACC2.43
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.9%
Revenue Next 2Y4.87%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%
ZOETIS INC / ZTS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?
ChartMill assigns a fundamental rating of 7 / 10 to ZTS.
Can you provide the valuation status for ZOETIS INC?
ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.
How profitable is ZOETIS INC (ZTS) stock?
ZOETIS INC (ZTS) has a profitability rating of 9 / 10.
Can you provide the expected EPS growth for ZTS stock?
The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 10.25% in the next year.
Is the dividend of ZOETIS INC sustainable?
The dividend rating of ZOETIS INC (ZTS) is 7 / 10 and the dividend payout ratio is 33.26%.